Business Context and Reporting Period
This Form 8-K filing by SANUWAVE Health, Inc. reports corporate governance events occurring on September 28, 2011. The company is a Nevada corporation headquartered in Alpharetta, Georgia.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Board Election: Barbara M. Henagan was elected to the Board of Directors on September 28, 2011, for a term expiring at the 2012 annual meeting of shareholders.
- Compensatory Arrangement: In connection with her election, Ms. Henagan was granted a stock option to purchase 25,000 shares of common stock.
- Option Terms: The options have an exercise price of $2.85 per share, were fully vested upon issuance, and expire on September 28, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. It strictly documents the appointment and associated compensation.
Investor Verification Checklist
- Verify the total number of outstanding shares and the potential dilution impact of the 25,000 new options granted.
- Confirm the current market price of SANUWAVE Health, Inc. stock relative to the $2.85 exercise price.
- Review the full text of the attached Press Release (Exhibit 99.1) for additional context on the board expansion.
- Check subsequent filings for the formal shareholder ratification of Ms. Henagan's election at the 2012 annual meeting.